LenioBio, a biotech company pioneering cell-free protein production, and Touchlight, a leader in enzymatic DNA production, have entered a supply agreement aimed at leveraging the capabilities of Touchlight’s rapid enzymatic doggybone DNA (dbDNA), to achieve unprecedented speed in vaccine development and manufacture in the context of LenioBio’s CEPI grant. LenioBio’s CEPI-funded project aims to showcase the capacity of their proprietary plant-based, cell-free ALiCE (Almost Living Cell-Free Ex...